BioHarvest Sciences Inc. Common Stock Total Assets
BioHarvest Sciences Inc. Common Stock total assets. Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) holds total assets worth $44.57 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BioHarvest Sciences Inc. Common Stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of BioHarvest Sciences Inc. Common Stock (2013–2025)
Total assets of BioHarvest Sciences Inc. Common Stock from 2013 to 2025. This chart illustrates how BioHarvest Sciences Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See BioHarvest Sciences Inc. Common Stock share price for real-time trading data and today's change.
BioHarvest Sciences Inc. Common Stock - Asset Composition Analysis
BioHarvest Sciences Inc. Common Stock Total Assets Breakdown (December 2025)
BioHarvest Sciences Inc. Common Stock total assets breakdown as of December 2025. BioHarvest Sciences Inc. Common Stock's total assets of $44.57 Million consist of 64.0% current assets and 36.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 48.3% |
| Accounts Receivable | $2.24 Million | 4.7% |
| Inventory | $4.56 Million | 9.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how BioHarvest Sciences Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore BHST working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BioHarvest Sciences Inc. Common Stock's current assets represent 64.0% of total assets in 2025, a decrease from 81.3% in 2013.
- Cash Position: Cash and equivalents constituted 48.3% of total assets in 2025, down from 81.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 9.6% of total assets.
BioHarvest Sciences Inc. Common Stock Competitors by Total Assets
Key competitors of BioHarvest Sciences Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
DXN HOLDINGS BHD.
KLSE:5318
|
Malaysia | RM2.16 Billion |
|
Emmi AG
SW:EMMN
|
Switzerland | CHF3.48 Billion |
|
Glanbia PLC
IR:GL9
|
Ireland | €3.99 Billion |
|
Grupo Bafar S.A.B. de C.V
MX:BAFARB
|
Mexico | MX$28.90 Billion |
|
Xinjiang Guannong Fruit & Antler Group Co Ltd
SHG:600251
|
China | CN¥7.31 Billion |
|
Shandong Oriental Ocean Sci-Tech Co Ltd
SHE:002086
|
China | CN¥1.59 Billion |
|
Ridley Corporation Ltd
AU:RIC
|
Australia | AU$1.64 Billion |
|
FRoSTA AG
F:NLM
|
Germany | €500.10 Million |
BioHarvest Sciences Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.24 | 0.60 | 3.49 |
| Quick Ratio | 1.75 | 0.36 | 3.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $14.50 Million | $-6.78 Million | $5.76 Million |
BioHarvest Sciences Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between BioHarvest Sciences Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.70 |
| Latest Market Cap to Assets Ratio | 0.71 |
| Asset Growth Rate (YoY) | 90.7% |
| Total Assets | $47.66 Million |
| Market Capitalization | $33.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values BioHarvest Sciences Inc. Common Stock's assets below their book value (0.71x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: BioHarvest Sciences Inc. Common Stock's assets grew by 90.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BioHarvest Sciences Inc. Common Stock (2013–2025)
The table below shows the annual total assets of BioHarvest Sciences Inc. Common Stock from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $47.66 Million | +90.65% |
| 2024-12-31 | $25.00 Million | +66.65% |
| 2023-12-31 | $15.00 Million | +59.71% |
| 2022-12-31 | $9.39 Million | -7.98% |
| 2021-12-31 | $10.21 Million | +92.46% |
| 2020-12-31 | $5.30 Million | +162.31% |
| 2019-12-31 | $2.02 Million | -51.66% |
| 2018-12-31 | $4.18 Million | +1286.22% |
| 2017-12-31 | $301.75K | +389.80% |
| 2016-12-31 | $61.61K | -15.54% |
| 2015-12-31 | $72.94K | +5.02% |
| 2014-12-31 | $69.46K | +30.04% |
| 2013-12-31 | $53.41K | -- |
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and w… Read more